Screener
Prime Medicine PRME Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies | ||
| Stockholders’ equity | ||
| Common stock, par value of $0.00001 per share; 775,000,000 shares authorized; 180,737,548 and 180,514,014 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in capital | 1,019,401 | 1,009,138 |
| Accumulated other comprehensive (loss) income | (9) | 82 |
| Accumulated deficit | (979,585) | (888,354) |
| Total stockholders’ equity | 39,809 | 120,868 |
| Total liabilities and stockholders’ equity | $249,040 | $342,733 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's total liabilities & equity?
- Prime Medicine (PRME) reported total liabilities & equity of $249.04M in Q2 2026.
- How has Prime Medicine's total liabilities & equity changed year-over-year?
- Prime Medicine's total liabilities & equity decreased by 10.7% year-over-year, from $279.01M to $249.04M.
- What is the long-term trend for Prime Medicine's total liabilities & equity?
- Over 4 years (2021 to 2025), Prime Medicine's total liabilities & equity has grown at a 3.2% compound annual growth rate (CAGR), from $301.86M to $342.73M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Prime Medicine's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude